Treatment of bacterial infection with oral interferon-α

dc.creator	Cummins, Joseph M.
dc.date.accessioned	2019-06-17T16:55:08Z
dc.date.available	2019-06-17T16:55:08Z
dc.date.issued	1998-10-06
dc.identifier.uri	https://hdl.handle.net/1969.1/176594
dc.description.abstract	Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The method is particularly suitable for the treatment of antibiotic-resistant infections. IFN-α is administered in solution or in the form of a saliva-dissolvable lozenge.	en
dc.language	eng
dc.publisher	United States. Patent and Trademark Office
dc.rights	Public Domain (No copyright - United States)	en
dc.rights.uri	http://rightsstatements.org/vocab/NoC-US/1.0/
dc.title	Treatment of bacterial infection with oral interferon-α	en
dc.type	Utility patent	en
dc.format.digitalOrigin	reformatted digital	en
dc.description.country	US
dc.contributor.assignee	The Texas A&M University System
dc.identifier.patentapplicationnumber	08/484376
dc.subject.uspcprimary	424/85.7
dc.subject.uspcother	424/435
dc.subject.uspcother	435/811
dc.date.filed	1995-06-07
dc.publisher.digital	Texas A&M University. Libraries
dc.subject.cpcprimary	A61K 38/212
dc.subject.cpcprimary	A61K 38/21
dc.subject.cpcprimary	Y10S 435/811